Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

South Korea says kids with suspected COVID-19 syndrome had another disease

Published 06/03/2020, 02:58 AM
Updated 06/03/2020, 03:00 AM

By Hyonhee Shin

SEOUL (Reuters) - Two children suspected to be South Korea's first cases of a life-threatening syndrome linked with the coronavirus were found to have contracted Kawasaki disease, a similar but separate infection, health authorities said on Wednesday.

The Korea Centers for Disease Control and Prevention (KCDC) said last week it had launched an investigation into two suspected cases of the "Multi-System Inflammatory Syndrome in Children" (MIS-C).

Officially called "Pediatric Multi-System Inflammatory Syndrome Potentially Associated with COVID-19", MIS-C cases have been reported in France, Italy, Spain and Britain and the United States, where more than 100 cases were found in the state of New York.

The symptoms of MIS-C are similar to toxic shock and Kawasaki disease, including fever, rashes, swollen glands and in severe cases, heart inflammation.

KCDC director Jeong Eun-kyeong said the investigation showed that both the two patients, an 11-year-old boy and a four-year-old girl, had suffered Kawasaki disease and shock syndrome.

Both children tested negative for the coronavirus and were released from hospital after receiving treatment, she said.

"After consulting an expert panel, we determined that neither of the two cases correspond to MIS-C," Jeong told a briefing.

"We're also examining a third suspected case that has been reported, though chances are low that it is MIS-C."

The syndrome has raised fears that COVID-19, the disease caused by the coronavirus, could pose a greater risk to children than had been understood. COVID-19 so far has taken its greatest toll on the elderly and those with chronic health conditions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Kim Ye-jin, a professor at Sungkyunkwan University's medical school who consulted the KCDC, said the expert panel is conducting research as the link between MIS-C and COVID-19 has not been clearly established globally.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.